Phathom Pharmaceuticals Q3 Adj. EPS $0.04 Beats $0.02 Estimate, Sales $84.722M Miss $85.096M Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings BeatsEarnings Misses
Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.02 by 100 percent. This is a 126.67 percent increase over losses of $(0.15) per share
Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.02 by 100 percent. This is a 126.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $84.722 million which missed the analyst consensus estimate of $85.096 million by 0.44 percent. This is a 71.14 percent increase over sales of $49.504 million the same period last year.